Compare Quant Healthcare Fund vs ICICI Prudential Healthcare Fund
Quant Healthcare Fund
ICICI Prudential Healthcare Fund
Risk
Very High
Very High
Rating
1.0
4.0
Min SIP Amount
₹1000
₹100
Expense Ratio
3.13
2.08
NAV
₹18.37
₹43.09
Fund Started
27 Jun 2023
25 Jun 2018
Fund Size
₹428.30 Cr
₹6995.62 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
16.22%
5.05%
3 Year
18.94%
20.97%
5 Year
-
15.06%
Equity
98.98%
95.01%
Cash
-4.55%
4.99%
Top 10 Holdings
Glaxosmithkline Pharmaceuticals Ltd. | 10.58% |
Glenmark Pharmaceuticals Ltd. | 9.83% |
Divi's Laboratories Ltd. Warrant | 9.46% |
Zydus Lifesciences Ltd. | 9.30% |
Pfizer Ltd. | 8.83% |
Alivus Life Sciences Ltd | 8.08% |
Torrent Pharmaceuticals Ltd. | 7.87% |
Concord Biotech Ltd. | 7.03% |
SMS Pharmaceuticals Ltd. | 6.71% |
Ipca Laboratories Ltd. | 6.22% |
Sun Pharmaceutical Industries Ltd. | 12.31% |
Dr. Reddy's Laboratories Ltd. | 8.26% |
Cipla Ltd. | 5.76% |
Mankind Pharma Ltd. | 5.21% |
Alkem Laboratories Ltd. | 4.87% |
Divi's Laboratories Ltd. | 4.83% |
Biocon Ltd. | 4.68% |
Medplus Health Services Ltd. | 4.15% |
Cohance Lifesciences Ltd. | 4.08% |
Syngene International Ltd. | 3.29% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
27 Jun 2023
25 Jun 2018
